CLINICAL HANDBOOK OF SCHIZOPHRENIA

Index 633Assessment of InterpersonalProblem Solving Skills, 140t,142Assessment of Motor and ProcessSkills, 140t, 142Association analyses, results of,62–63Atherosclerosis, comorbid, 432At-risk mental state, 381Atrium, approach and targetpopulation, 456tAuditory hallucinations, 83in children, 482Autonomy, versus externalcontrol, spirituality/religionand, 600–601Avolition, 88Barefoot doctor system, 552–553Barriers to Employment andCoping Efficacy Scale, 140t,143Basal ganglia, findings inschizophrenia, 45t, 51Baseline exaggeration, 441BASIS-32, characteristics andinformation sources, 139tBehavior, disorganization of, 87Behavior and SymptomIdentification Scale, 138Behavioral experiments, 236Behavioral reattribution, 236–237Behavioral response, 241Behavioral tailoring, researchevidence for, 269Beliefs. See Patient beliefsBeneficence, principle of, 627,627tBenzodiazepines, 189–190side effects, 190Beyond Trauma, approach andtarget population, 456tBioethics, theories in, 624Biological theories, 25–34early, 25–26environmental factors in, 26genetic factors in, 27–28and mechanism of action ofantipsychotic drugs, 29–32neuroanatomical abnormalitiesin, 26–27neurochemical hypotheses in,28–29phenomenology andpharmacology and, 32–33Bipolar disorderin adolescents, 483clozapine for, 180ECT indicated for, 197Birth, season of, 19–20Blood glucose testing, 130–131Blood testing, for substanceabuse, 127Board and care homes, 350Borderline personality disorder, inchildren, 483Boston Mental Patients’Liberation Front, 301Bowring v. Godwin, 356Braindecreased volume, 46fetal, gender differences in, 576findings in schizophrenia, 8–9,45tglobal findings, 46–47ventricular enlargement, 46–47Brain abnormalitiesassessment for, 370tgender and, 577in utero development and, 101Brain imaging, 35–43functional, 37–42electroencephalography, 40–41fMRI, 39–40future directions in, 42interpretative challenges in,41–42magnetoencephalography, 40–41PET and SPECT, 38–39future directions, 42–43structural, 36–37CT, 36MRI, 36–37MRS, 37Brain injury, intellectual disabilitydue to, 439Breast feedingfirst-generation antipsychoticsduring, 475second-generationantipsychotics and, 476Breathalyzer, 127BRIDGES, 303–304Brief advice, 467–468Brokering, case manager’s role in,311–312, 311tBupropion, 192CAGE, 126Camberwell Assessment of Need,139t, 141Cannabispsychosis and, 26schizophrenia symptoms and,460, 462, 464Capacity, patient, defined, 521–522Carbamazepine, 188agranulocytosis and, 182Cardiovascular disorders, cooccurring,132Cardiovascular side effects,clozapine-related, 182–183Caregiving, family, economicvalue of, 510Case ascertainment, methods of, 15Case managementbroker model of, 319for first-episode psychosis, 373homelessness and, 415–416strengths-based. See Strengthsbasedcase managementCase management movement,309–310. See also Clinicalcase managementCase manager–consumerrelationship, 322Case managers, roles of, 310–314, 311tCaspi Study, 618Catatonia, 3benzodiazepines for, 190DSM-IV-TR definition, 87ECT indicated for, 198Catatonic behavior, ICDdefinitions, 89Catechol-O-methyltransferase, 11gender and, 575CBT. See Cognitive-behavioraltherapyCBT for PTSD among PublicSector Consumers, approachand target population, 456tCBT for PTSD in SMI, approachand target population, 456tCentral Intelligence Agency,clinical experiments by, 626Central nervous system disorders,intellectual disability due to.See Intellectual disabilityCentral nervous system injuries,filter effects of, 441Cerebellum, changes in, 50Changing Your Thinking module,283–285Child abuse, among homelesspeople with schizophrenia,413Child abuse/neglect, intellectualdisability due to, 439Child sexual abuse, 76Childhood development, genderand, 576Childhood-onset schizophrenia,52, 481–484differential diagnosis of, 482–483See also Early-onsetschizophrenia